The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes

by Francesca Iannantuoni, Aranzazu M. de Marañon, Noelia Diaz-Morales, Rosa Falcon, Celia Bañuls, Zaida Abad-Jimenez, Victor M. Victor, Antonio Hernandez-Mijares, Susana Rovira-Llopis
Published 2019-11-01

Altered mitochondrial function and oxidative stress in leukocytes of anorexia nervosa patients.

by Victor M Victor, Susana Rovira-Llopis, Vanessa Saiz-Alarcon, Maria C Sangüesa, Luis Rojo-Bofill, Celia Bañuls, Rosa Falcón, Raquel Castelló, Luis Rojo, Milagros Rocha, Antonio Hernández-Mijares
Published 2014-01-01

Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

by Francisco Canet, Francesca Iannantuoni, Aránzazu Martínez de Marañon, Pedro Díaz-Pozo, Sandra López-Domènech, Teresa Vezza, Blanca Navarro, Eva Solá, Rosa Falcón, Celia Bañuls, Carlos Morillas, Milagros Rocha, Víctor M. Víctor
Published 2021-07-01